The Blue Swan

Tal David and Amit Ben Kish: The Singularity is Here in Parallels with Quantum Art

The Quantum Revolution: A Paradigm Shift for AI Synergy Tal David and Amit Ben Kish, founders of Quantum Art, describe quantum computing not merely as an upgrade to existing software, but as a fundamental hardware paradigm shift. While AI remains a software revolution running on traditional CPUs and GPUs, quantum computing utilizes Quantum Processing Units (QPUs) to solve problems with a completely different logic. Tal highlights three massive implications of this technology: accelerating specific AI workloads by factors of a million or more, drastically reducing energy consumption compared to current AI data centers, and creating a “two-way street” where AI helps design more complex quantum systems. Amit emphasizes that their trapped-ion architecture allows for exponential memory and computational space, enabling calculations—such as complex chemical reactions—that are physically impossible for classical computers to store or process. The company is focused on the intense capital and engineering effort required to integrate optics, vacuum systems, and quantum physics into a commercially viable product. Ions and Multi-Qubit Gates: A Quantum Mosaic Quantum Art’s technical strategy centers on the use of trapped ions, which Amit describes as “nature’s perfect qubits.” Unlike superconducting modalities that require cooling entire massive fridges to near absolute zero, Quantum Art uses lasers to cool only the ions themselves, significantly increasing efficiency. To overcome the inherent noise in quantum systems, the team employs a “logical qubit” approach, bunching physical qubits together to fix errors faster than they occur. Their unique architecture utilizes multi-qubit gates—“beasts” capable of performing thousands of operations in a single step—and a reconfigurable “Quantum FPGA” design that allows them to compress complex circuits into a tiny physical footprint. The Advantage of Quantum-AI Symbiosis: 2027 and Beyond Tal outlines two critical milestones for the industry: the “Quantum Advantage” moment and “Utility Scale.” Quantum advantage—the point where a quantum computer surpasses the world’s most powerful supercomputers on commercially relevant problems—is expected as early as late 2027 or 2028. This requires roughly 50 to 100 noiseless, logical qubits. The broader utility scale, involving systems with a million qubits capable of unlocking the technology’s full potential, is projected for the mid-next decade. Hybrid quantum-classical AI data centers are expected to consume orders of magnitude less energy than today’s AI data centers. Tal notes that this shift could eliminate the need for energy-intensive solutions like nuclear-powered data centers, making quantum computing a cornerstone of sustainable technology. While the hardware will likely remain in data centers rather than iPhones, Tal notes that “Quantum as a Service” already allows users to access this power via the cloud. Lights, Camera, Quantum: From Drug Discovery to Digital Art The versatility of quantum computing allows mathematical solutions in one field to migrate seamlessly to others. Tal explains how solving the wave equation for telecommunications—analyzing signal propagation through buildings—can be mapped directly onto computer animation to simulate ocean waves with extreme precision. The technology is poised to disrupt pharma through high-complexity molecular modeling, finance through fraud detection, and logistics through traffic optimization. By using sophisticated compilers and transpilers, Quantum Art aims to make this transition invisible to the end-user, providing a software-like experience backed by quantum hardware. Building a World-Class Infrastructure on a Nobel Foundation The genesis of Quantum Art is rooted in elite academia and deep-tech experience. Amit reflects on his time working at NIST Boulder with Nobel laureate Dave Wineland, whose “Bible” of quantum processes laid the groundwork for the industry twenty-five years ago. Spun out of the Weizmann Institute in 2022, Quantum Art has rapidly scaled to a team of over 60 specialists from institutions like Stanford and Harvard, as well as industry giants like Intel and Google. The New York Stock Exchange foreshadowed their future with an honorable mention after raising a record-breaking $140 million Series A. Testing the Waters: The Temperature is Right Tal concludes that quantum computing is no longer science fiction; it is an approaching reality that requires a “paradigm shift” in organizational thinking. He notes that most Fortune 500 companies are already “testing the temperature” by developing applications today. His advice to technological organizations is direct: “get your hands dirty” by using simulators and working with hardware providers now to prepare for the imminent quantum revolution. Get full access to Seantzu at seantzu.substack.com/subscribe [https://seantzu.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_4]

Edwin Mata: Diamonds are a Token's Best Friend but Royalties are Forever

Revolutionizing Asset Tokenization: Simplicity, Speed, and Structure Edwin Mata demystifies tokenization as the process of transforming real-world assets—such as real estate, equities, intellectual property, and luxury goods—into digital tokens that can be divided, distributed, and settled on a blockchain. Brickken’s platform streamlines the traditionally complex and bureaucratic world of securitization, enabling capital formation with unprecedented speed and efficiency. Crucially, Edwin emphasizes that tokenization is not a regulatory loophole; it is an efficiency layer that operates strictly within existing legal frameworks. “If something is not legal to be securitized or offered to the public, then it won’t be tokenized,” he asserts. Brickken’s technology accelerates compliant processes, offering features like T+0 settlement and one-click dividend distribution. The Power of Intangible Assets: IP, Royalties, and Entertainment Brickken’s mission extends beyond tangible assets to the world of intangibles—intellectual property, royalties, music licensing, film rights, and event access. Edwin explains how tokenization empowers creators—musicians, filmmakers, and artists—to monetize their work and unlock new revenue streams, all while maintaining control and compliance. He highlights the challenges of navigating complex legal frameworks, such as sync licensing in music or FIFA’s strict IP rules for athletes. Brickken’s adaptable technology ensures that each asset’s unique legal structure is respected, empowering creators without overstepping regulatory boundaries. Bridging the Gap Between Technology and Regulation Compliance is at the heart of Brickken’s approach. Edwin details how the platform integrates Know Your Customer (KYC) protocols and accreditation checks to ensure offerings meet local securities laws. In the U.S., Brickken’s system enforces regulatory guardrails—blocking non-accredited investors and tailoring processes to frameworks like Regulation D. In Europe, the platform aligns with MiFID II and adapts to country-specific requirements. “We format the technology for you to be compliant under the regulation that you’re trying to enact,” Edwin explains, positioning Brickken as both an innovation engine and a compliance backbone. Tokenization Across All Asset Classes: From Diamond Rings to Biotech Startups Brickken is redefining investor access to a diverse array of asset classes—from Picasso paintings and diamond rings to biotech startups and film productions. Tokenization democratizes access to previously illiquid markets, allowing investors to participate in short-term, high-yield opportunities once reserved for institutions. Edwin notes, however, that investor appetite often favors short-duration, high-liquidity, high-yield instruments—a reflection of Web3’s culture of instant liquidity. Successfully blending these expectations with the realities of real-world assets requires careful calibration and robust corporate governance, ensuring legal authority is established before tokenization proceeds. Valuation, Trust, and the Role of Certified Partners Trust and transparency are central to Brickken’s model. The platform offers best-practice valuation guidance and connects issuers with certified valuation partners worldwide. These assessments can be embedded directly into smart contracts, creating a verifiable trust link between an asset’s value and what investors purchase. This is especially vital for early-stage or independent issuers who may lack established financial histories. While Brickken is not an auditor, its network of partners ensures credibility and rigor for every offering. The Derivatives Dilemma: Why Real-World Assets Are Not Digital-Native Edwin addresses the complexities of creating derivatives for tokenized real-world assets. Unlike digital assets or commodities with real-time valuation and deep liquidity, real-world assets—like art or private equity—lack 24/7 valuation infrastructure. Attempting to create derivatives in such markets risks generating “fake markets” and destabilizing early participants. Edwin cautions against treating real-world assets as digital-native, emphasizing the need for robust market makers, liquidity providers, and real-time data before derivatives can safely flourish in this space. The Future of Tokenized Ecosystems: AI, Real-Time Valuation, and Mass Digitization Looking forward, Edwin envisions artificial intelligence as a game-changer for real-time asset valuation. AI agents could continuously scan financial data and provide live valuation signals, unlocking the full potential of tokenized ecosystems. However, he warns that continuous information flow is a double-edged sword—real-time exposure could destabilize smaller companies not ready for public scrutiny. The goal is to balance transparency and efficiency with the stability needed for early-stage issuers to thrive. A Vision for the Future: The Great Digitization Edwin predicts a sweeping shift toward the mass digitization of private markets over the next decade. The trillions locked in illiquid asset classes—luxury goods, private credit, entertainment IP, biotech, fine art—represent vast untapped value. Brickken aims to be the infrastructure that unlocks this potential. “Even this incipient market might take five to ten years,” Edwin says, “but in the future, all will be digitized. We’re heading toward a mass digitization where there’s going to be a lot of value extracted from private, previously inaccessible markets—and I think we are really going to be living in an incredibly exciting world in the next ten years.” Get full access to Seantzu at seantzu.substack.com/subscribe [https://seantzu.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_4]

Eze Abosi: Backed by Novartis to Feed Your Head with AI Drug Development

Visionary Leadership in Life Sciences Eze Abosi is a trailblazer in the life sciences industry, leveraging over 20 years of expertise in healthcare, data analytics, and consulting to reshape how clinical and genomic data are utilized to improve patient care. As the Chief Growth Officer at Holmusk, a Series B-stage medical technology company backed by Novartis, Abosi leads sales, marketing, and service functions, driving the company’s mission to redefine neuropsychiatry and neuroscience research. Under his leadership, Holmusk has become a critical player in the integration of clinical and genomic data, empowering researchers, healthcare providers, and biopharma companies to address the most complex challenges in healthcare. Psychedelics: A New Dimension in Mental Health Abosi and Holmusk are at the cutting edge of psychedelic drug development, a burgeoning field that promises to revolutionize the treatment of mental health disorders. As the U.S. FDA and other global regulators begin to fast-track the approval of psychedelic therapies, Holmusk plays a critical role by providing enriched datasets that help biotech companies like Compass Pathways and Atai Life Sciences advance their clinical trials. Abosi highlights the transformative potential of psychedelics, such as psilocybin and MDMA, in treating mental health conditions like depression and anxiety. With a focus on data enrichment, Holmusk supports these organizations by creating high-quality evidence to showcase the efficacy and safety of psychedelic therapies. “The lack of significant side effects in psychedelics, compared to traditional treatments like benzodiazepines, makes them a game-changer for patients,” Abosi explains. Holmusk is also helping to bridge the gap between hallucinogenic properties and therapeutic benefits by supporting research into second-generation psychedelics that isolate medicinal properties while minimizing hallucinogenic effects. AI Drug Development: Accelerating Discovery with Data Artificial intelligence in drug development is one of the most exciting and challenging frontiers in healthcare, and Abosi is positioning Holmusk at its forefront. By integrating high-quality, curated clinical data with cutting-edge machine learning techniques, Holmusk enables biopharma companies to de-risk the critical early stages of drug discovery and clinical research. Abosi explains that Holmusk’s datasets are particularly valuable for AI applications that aim to characterize patient populations and identify underserved subgroups. This capability is especially relevant in central nervous system (CNS) disorders, where Holmusk’s enriched datasets allow researchers to stratify patients by symptoms and develop therapies targeted at specific subpopulations, such as acute anxiety or treatment-resistant depression. Despite the potential of AI in drug development, Abosi notes that progress has been relatively slow, often stalling at Phase 2 trials. However, Holmusk is working to change that by fostering collaborations with researchers and biotech firms to accelerate the application of AI in clinical trials and commercialization. “AI is only as good as the data it’s applied to,” Abosi says. “Our role is to ensure that the data is robust, enriched, and capable of driving breakthroughs in drug development.” Pioneering the Intersection of Physical and Mental Health One of Holmusk’s most groundbreaking achievements lies in its ability to link physical and mental health outcomes through data. Abosi points to collaborations with institutions like Oxford University and Stanford’s Bioinformatics Department as examples of how Holmusk is breaking down silos in healthcare. A notable study conducted in partnership with Oxford explored correlations between GLP-1 medications (commonly used for cardiometabolic conditions) and mental health outcomes. Holmusk’s enriched datasets revealed meaningful insights into how these medications not only improve physical health but also impact cognitive function and mental health disorders like anxiety and depression. “This research represents the holy grail of healthcare,” Abosi says. “By looking at the patient holistically, we can establish critical links between physical and brain health.” The Skinny on GLP-1: Redefining Drug Market Access Beyond research and development, Abosi is driving innovation in how drugs are commercialized and accessed. Holmusk collaborates with payers, pharma companies, and healthcare providers to create robust economic stories for new therapies. This is particularly critical in CNS disorders, where traditional approaches to drug development and commercialization often fall short. For example, Holmusk helps manufacturers demonstrate the economic value of their therapies by showing how premium-priced medications can reduce overall healthcare costs. Abosi provides the example of GLP-1 medications: although more expensive than generics like Metformin, GLP-1s have been shown to reduce long-term healthcare costs by improving both physical and mental health outcomes. “Our data enables manufacturers to create compelling value stories that secure better formulary placements and ultimately improve access for patients,” Abosi explains. Driving Innovation in Neuropsychiatry and Neuroscience Holmusk’s mission extends beyond supporting biopharma companies—it aims to elevate the entire field of neuropsychiatry and neuroscience to the same level of precision and rigor seen in other therapeutic areas like oncology or cardiology. By enriching datasets with behavioral, clinical, and genomic information, Holmusk enables researchers to better understand the full scope of CNS disorders and develop targeted interventions that address unmet needs. Abosi also emphasizes the role of Holmusk in fostering collaborations between academic institutions, healthcare providers, and biopharma companies. These partnerships are critical for advancing research in complex areas like schizophrenia, bipolar disorder, and substance use disorders, where traditional data sources often fall short. A Vision for the Future Eze Abosi’s work at Holmusk represents a bold vision for the future of healthcare. By integrating cutting-edge technologies like AI, advancing psychedelic drug development, and breaking down silos between physical and mental health, Abosi is reshaping how the life sciences industry approaches patient care. “What excites me most is the potential to create a better healthcare ecosystem—one that looks at the patient holistically and leverages data to drive innovation,” Abosi says. With his leadership, Holmusk is not only advancing the field of neuropsychiatry but also setting a new standard for how data and technology can transform healthcare as a whole. Through his relentless focus on data, collaboration, and innovation, Eze Abosi is proving that the future of healthcare lies at the intersection of science, technology, and human-centered care. Get full access to Seantzu at seantzu.substack.com/subscribe [https://seantzu.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_4]

Aron D’Souza: The Enhanced Game of Hulk Hogan vs. Gawker and Birth of Objection AI

Aron D’Souza is not just a founder—he’s a visionary disruptor. From masterminding the revolutionary Hulk Hogan vs. Gawker lawsuit that redefined accountability in the media, to creating Objection AI, a groundbreaking truth arbitration platform, D’Souza’s career has been defined by audacity and relentless ambition. In this episode, he shares his journey of challenging societal norms and reshaping industries, offering a masterclass in leadership, innovation, and the art of building transformative ventures. The Gawker Lawsuit: A Blueprint for Accountability Aron D’Souza’s rise to prominence began with a chance encounter at Oxford University in 2009, where he met Peter Thiel, the legendary venture capitalist and investor in Facebook, Spotify, and Palantir. What started as a casual conversation about media accountability turned into a five-year, $10 million legal crusade that culminated in a $140 million judgment for Hulk Hogan and the bankruptcy of Gawker Media. D’Souza reflects on the pivotal moment when he proposed his idea to Thiel: “I probably said the most important words of my life—‘If you don’t want to sue them, why don’t you find someone who wants to, but doesn’t have the financial resources to do so?’” The rest is history. The case, which remains one of the most consequential media lawsuits in American history, demonstrated the power of strategy, resilience, and focus. Now, D’Souza is taking the lessons from that legal battle and applying them to his latest venture, Objection AI, compressing the time and cost of holding media outlets accountable from years and millions of dollars to just weeks and a fraction of the price. Objection AI: The Court for the Internet With Objection AI, D’Souza is tackling one of the most pressing issues of the digital age: the absence of a reliable truth arbitration system for the internet. This revolutionary platform allows individuals to challenge misinformation and media bias using a process inspired by both the judiciary and the scientific method. For as little as $2,000, Objection AI’s team of investigators—comprised of former CIA and FBI agents—analyzes media claims, compiles evidence, and creates a public data room for transparency. The journalist or media outlet in question is invited to respond, creating an adversarial process that mirrors a court of law. “Truth isn’t a vibe; truth is a process,” D’Souza asserts. He explains how the platform leverages both human expertise and AI to ensure rigorous truth-seeking. “The internet doesn’t have a native truth adjudication layer. Anyone can write anything, and it’s incredibly difficult to challenge false information. Objection AI changes that.” With a long-term vision of becoming “the court for everything,” Objection AI is poised to replace the judiciary’s slow-moving processes with an efficient, scalable alternative. “Even the wealthiest individuals can struggle to access justice in today’s legal system,” D’Souza notes. “We’re building a platform where truth is accessible to everyone.” The Enhanced Games: Superhuman Achievement Redefined D’Souza’s ambition doesn’t stop at media accountability. As the president of the Enhanced Games, a $2.5 billion company poised to go public and challenge the Olympics, he’s redefining the limits of human potential. The Enhanced Games embraces performance-enhancing technologies under medical supervision, positioning itself as a bold alternative to traditional sports competitions. “The Olympics celebrates outdated ideals,” D’Souza says. “The Enhanced Games is about celebrating the future—pushing the boundaries of what humanity can achieve.” Guided by a scientific advisory board that includes luminaries like George Church, the world-renowned geneticist and co-founder of Colossal Biosciences, the Enhanced Games is breaking new ground in both sports and science. D’Souza credits Church’s involvement as pivotal, explaining how he cold-emailed the Harvard professor with his vision: “He didn’t even need the pitch. He just said, ‘I’m in. Let’s get to work.’” Together, they’ve developed groundbreaking protocols for enhancing athletes, turning the Enhanced Games into a global platform for superhuman innovation. Leadership Lessons from Rugby and Startups D’Souza’s leadership style is deeply influenced by his time playing rugby at Oxford. “Rugby is simple—you have a unified goal: to win,” he says. This clarity of purpose has carried over into his ventures. Whether it’s the Enhanced Games or Objection AI, D’Souza emphasizes the importance of focus and mission-driven leadership. “Every great business feels a little bit dangerous,” he reflects. “Airbnb, Uber, OpenAI—they all started by challenging entrenched systems. The same is true for Objection AI and the Enhanced Games.” Having founded 12 startups with five successful exits, D’Souza has learned that talent is the most critical ingredient for success. “Strategy and capital are commodities,” he explains. “What sets a great company apart is its ability to attract top-tier talent. And that comes down to mission. People want to work on something that matters.” Cold Emails, Bold Moves, and the Hollywood Connection D’Souza’s career is a testament to the power of boldness. From cold-emailing billionaires and Harvard professors to pitching Peter Thiel in his first week at Oxford, he’s never been afraid to take risks. “You can literally do anything,” he insists. “A lot of people just sit there waiting for opportunities to come to them. But you can make your own destiny.” This audacity extends to Hollywood, where the Hulk Hogan vs. Gawker story is being adapted into a feature film, with Matt Damon and Ben Affleck rumored to star. “Hollywood moves at a snail’s pace compared to Silicon Valley,” D’Souza jokes. “In the time it takes them to make a movie, we can build a unicorn.” A Legacy of Disruption and Impact From toppling media empires to pioneering truth arbitration and superhuman athletics, Aron D’Souza’s career is defined by fearless innovation and a refusal to accept the status quo. Whether he’s challenging the judiciary, reimagining competitive sports, or creating new systems of accountability, D’Souza is driven by a singular mission: to build a better world through bold, transformative ideas. “Every great business feels a little bit dangerous,” he says. “That’s how you know you’re onto something big.” In this episode, discover how Aron D’Souza is challenging the status quo—and winning. Get full access to Seantzu at seantzu.substack.com/subscribe [https://seantzu.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_4]

Martin Percy: Resuscitating Lions at the Gate of Deep Mind with Interactive Emmys, Webbys, and BAFTAs

Interactive Video: Educating and Empowering Audiences Martin Percy has spent his career championing the power of interactive video to create real-world impact. While many dismiss interactive films as gimmicks, Percy has mastered the art of using interactivity to engage audiences in ways that linear formats cannot. His Emmy, BAFTA, and Webby award-winning CPR training films, for instance, are backed by peer-reviewed medical research proving they are just as effective as hands-on training sessions with live instructors—at a fraction of the cost. These videos, which empower viewers to make life-saving decisions, have been rolled out nationwide in Canada and are set to launch in the U.S. under the “Cardiac Star” initiative. AI in Film: From the Impossible to Reality For over a decade, Percy dreamed of creating films that teach audiences how to survive life-threatening scenarios like fires, but logistical and budgetary constraints made such projects impossible. Enter AI-generated video. With the backing of Google DeepMind, Percy brought his long-held vision to life with Flashover, an AI-powered fire safety film that places viewers in the heart of a burning building, teaching them how to escape. AI tools allowed Percy to depict scenes that were once too dangerous or expensive to film traditionally. The Ethics of AI and the Culture War As AI increasingly infiltrates the creative industries, it has sparked fierce debate, particularly in film. He has observed a growing cultural divide: while mainstream media embraces AI for its cost-saving and creative potential, many in the indie and artistic communities are rejecting it outright. Percy highlights the call for human-centered storytelling, with some advocating for AI-free zones in filmmaking, including festivals and industry awards. The rise of AI-free certifications reflects a broader societal desire for authentic human creativity. While Percy doesn’t see AI as a cultural enemy, he recognizes the ethical dilemmas of this new technological frontier and remains committed to using it responsibly, particularly in projects with high social utility. The Future of Storytelling: Indie Creators and AI Tools For Percy, the future of storytelling lies at the intersection of AI and human creativity. AI tools are already enabling indie creators to overcome traditional barriers such as limited budgets and logistical challenges. By democratizing access to high-quality production, AI is empowering filmmakers to bring ambitious ideas to life—whether it’s building immersive historical worlds or creating impossible-to-shoot safety films. However, Percy is quick to note that AI is not a replacement for human artistry. Instead, he sees it as a powerful enabler that bridges the gap between imagination and execution. AI’s Role in Awards and Industry Standards The embrace of AI in filmmaking has also reached the highest levels of recognition, with the Oscars and other major institutions exploring the inclusion of AI-specific categories. However, Percy predicts a backlash. As opposition to AI grows, particularly among actors and creators within the film industry, we may see a shift away from AI-influenced projects in awards circuits. While some productions might leverage AI for special effects or logistical efficiency, Percy believes the human element will remain central to premium storytelling. Nevertheless, for mass-market productions, the allure of AI’s cost-efficiency and rapid advancements may prove unstoppable. Percy’s nuanced perspective highlights the tension between technological innovation and the preservation of human creativity—a debate that will shape the entertainment industry for years to come. Get full access to Seantzu at seantzu.substack.com/subscribe [https://seantzu.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_4]